查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587151

臨床風險分組解決方案市場：按產品、部署模式和最終用戶 - 2025-2030 年全球預測

Clinical Risk Grouping Solution Market by Product (Dashboard Analytics Solutions, Risk Reporting Solutions, Scorecards & Visualization Tools), Deployment Mode (Private Cloud, Public Cloud), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床風險分組解決方案市值為9.2517億美元，預計到2024年將達到10.5219億美元，複合年成長率為13.82%，到2030年將達到22.8995億美元。

臨床風險分組解決方案 (CRGS) 市場專注於開發先進工具，旨在根據患者的臨床風險狀況對患者進行分類。 CRGS 的主要範圍是透過實現個人化、資料驅動的護理管理來改善醫療保健結果。這些解決方案使醫療保健專業人員能夠識別高風險患者並相應地制定干涉措施，對於減少醫療錯誤、降低醫療成本和改善患者治療效果至關重要。最終用途多種多樣，包括醫院、保險公司和政府附屬醫療機構，應用包括醫療保健政策設計、保險風險評估和醫院資源管理。市場成長的關鍵驅動力是醫療保健中資料分析的日益採用、對護理品質和效率的日益關注以及患者照護需求的日益複雜性。醫療保健支出的快速成長和監管對基於價值的護理模式的推動進一步推動了需求。

主要市場統計
基準年[2023] 9.2517 億美元
預測年份 [2024] 1,052,190,000 美元
預測年份 [2030] 228,995萬美元
複合年成長率（%） 13.82%

最新的潛在機會來自人工智慧和機器學習等技術進步，這些技術進步提高了 CRGS 的預測準確性和效率。市場參與者可以透過專注於將這些技術整合到他們現有的解決方案中來獲得顯著的利益。此外，在這些地區醫療保健系統數位轉型的推動下，向新興市場的擴張是另一條成長途徑。然而，挑戰依然存在，包括高昂的實施成本、資料隱私問題以及適應現有醫療保健 IT 生態系統所需的微妙整合。此外，醫療保健專業人員對變革的抵制和技能差距阻礙了無縫實施。

創新的機會在於開發使用者友善的介面，需要最少的培訓和改進互通性標準，以確保平台之間的無縫資料流。 CRGS 市場反映了技術與醫療保健的動態交叉，透過客戶回饋和技術進步進行持續創新對於保持競爭力至關重要。對於希望利用這一快速成長的市場格局的企業來說，注重合作夥伴關係並保持在監管環境中的領先地位至關重要。

市場動態：針對快速發展的臨床風​​險分組解決方案市場揭示的關鍵市場見解

供需的動態交互作用正在改變臨床風險分組解決方案市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 更加關注患者風險管理
    • 透過在醫療保健產業引入巨量資料來改變臨床結果
    • 風險管理解決方案的好處
  • 市場限制因素
    • 缺乏基礎設施以及資本集中臨床解決方案
  • 市場機會
    • 人們越來越關注人工智慧和機器學習
    • 健康檔案記錄與維護普及
    • 由於文件需求增加了醫生的倦怠
  • 市場挑戰
    • 病患資料隱私問題

波特五力：駕馭臨床風險分組解決方案市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對臨床風險分組解決方案市場的外部影響

外部宏觀環境因素在塑造臨床風險分組解決方案市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臨床風險分組解決方案市場的競爭格局

臨床風險分組解決方案市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣臨床風險分組解決方案市場供應商的績效評估

FPNV 定位矩陣是評估臨床風險分組解決方案市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製臨床風險分組解決方案市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，臨床風險分組解決方案市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 關注患者風險管理
      • 透過在醫療保健產業引入巨量資料來改變臨床結果
      • 風險管理解決方案的好處
    • 抑制因素
      • 缺乏基礎設施和資本集中臨床解決方案
    • 機會
      • 人工智慧和機器學習引起越來越多的關注
      • 介紹健康記錄記錄和維護
      • 由於文件要求增加了醫生的倦怠
    • 任務
      • 病患資料隱私問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章臨床風險分組解決方案市場：依產品

  • 儀表板分析解決方案
  • 風險報告解決方案
  • 記分卡和視覺化工具

第7章臨床風險分組解決方案市場：依部署模式

  • 私有雲端
  • 公共雲端

第8章臨床風險分組解決方案市場：按最終用戶分類

  • 門診治療中心
  • 醫院
  • 長期照護中心
  • 付款人

第9章美洲臨床風險分組解決方案市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太臨床風險分組解決方案市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲臨床風險分組解決方案市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Conduent, Inc.
  • Dynamic Healthcare Systems, Inc. by Reveleer
  • Evolent Health
  • HBI Solutions, Inc.
  • Health Catalyst Inc.
  • Johns Hopkins University
  • Lightbeam Health Solutions, LLC
  • Optum Inc. by UnitedHealth Group
  • Perahealth, Inc.
Product Code: MRR-034230D3E675

The Clinical Risk Grouping Solution Market was valued at USD 925.17 million in 2023, expected to reach USD 1,052.19 million in 2024, and is projected to grow at a CAGR of 13.82%, to USD 2,289.95 million by 2030.

The Clinical Risk Grouping Solution (CRGS) market represents a segment focused on developing sophisticated tools designed to categorize patients based on their clinical risk profiles. The primary scope of CRGS is to enhance healthcare outcomes by enabling personalized and data-driven care management. These solutions are essential in reducing medical errors, lowering healthcare costs, and improving patient outcomes by allowing providers to identify high-risk patients and tailor interventions accordingly. Applications include healthcare policy design, insurance risk assessment, and hospital resource management, with end-use spanning hospitals, insurance companies, and governmental health agencies. Market growth is primarily driven by the increasing adoption of data analytics in healthcare, growing emphasis on quality care and efficiency, and the rising complexity of patient care needs. The surge in healthcare expenditure and the regulatory push toward value-based care models further bolster demand.

KEY MARKET STATISTICS
Base Year [2023] USD 925.17 million
Estimated Year [2024] USD 1,052.19 million
Forecast Year [2030] USD 2,289.95 million
CAGR (%) 13.82%

Latest potential opportunities arise from technological advancements like AI and machine learning, which enhance the predictive accuracy and efficiency of CRGS. Market players could benefit significantly by focusing on integrating these technologies into existing solutions. Furthermore, expansion into emerging markets, fueled by the digital transformation of healthcare systems in these regions, presents another avenue of growth. However, challenges persist, such as high implementation costs, data privacy concerns, and the nuanced integration required to fit existing healthcare IT ecosystems. Moreover, resistance to change and skill gaps among healthcare professionals impede seamless adoption.

Innovation opportunities lie in developing user-friendly interfaces that require minimal training and improving interoperability standards to ensure seamless data flow across platforms. The CRGS market reflects a dynamic intersection of technology and healthcare, where continuous innovation driven by customer feedback and technological progress is essential for staying competitive. Emphasizing collaborative partnerships and staying abreast of regulatory changes will be vital for companies aiming to capitalize on this burgeoning market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Risk Grouping Solution Market

The Clinical Risk Grouping Solution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing focus on patient's risk management
    • Implementation of big data in the healthcare industry to transform clinical outcomes
    • Advantages of risk management solutions
  • Market Restraints
    • Lack of infrastructure coupled with capital intensive clinical solutions
  • Market Opportunities
    • Increasing focus on AI and machine learning
    • Adoption of recording and maintaining the health records
    • Increasing physician burnout due to documentation needs
  • Market Challenges
    • Patient data privacy concerns

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Risk Grouping Solution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Risk Grouping Solution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Risk Grouping Solution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Risk Grouping Solution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Risk Grouping Solution Market

A detailed market share analysis in the Clinical Risk Grouping Solution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Risk Grouping Solution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Risk Grouping Solution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Risk Grouping Solution Market

A strategic analysis of the Clinical Risk Grouping Solution Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Risk Grouping Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Conduent, Inc., Dynamic Healthcare Systems, Inc. by Reveleer, Evolent Health, HBI Solutions, Inc., Health Catalyst Inc., Johns Hopkins University, Lightbeam Health Solutions, LLC, Optum Inc. by UnitedHealth Group, and Perahealth, Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Risk Grouping Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Dashboard Analytics Solutions, Risk Reporting Solutions, and Scorecards & Visualization Tools.
  • Based on Deployment Mode, market is studied across Private Cloud and Public Cloud.
  • Based on End User, market is studied across Ambulatory Care Centers, Hospitals, Long-Term Care Centers, and Payers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing focus on patient's risk management
      • 5.1.1.2. Implementation of big data in the healthcare industry to transform clinical outcomes
      • 5.1.1.3. Advantages of risk management solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of infrastructure coupled with capital intensive clinical solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing focus on AI and machine learning
      • 5.1.3.2. Adoption of recording and maintaining the health records
      • 5.1.3.3. Increasing physician burnout due to documentation needs
    • 5.1.4. Challenges
      • 5.1.4.1. Patient data privacy concerns
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Risk Grouping Solution Market, by Product

  • 6.1. Introduction
  • 6.2. Dashboard Analytics Solutions
  • 6.3. Risk Reporting Solutions
  • 6.4. Scorecards & Visualization Tools

7. Clinical Risk Grouping Solution Market, by Deployment Mode

  • 7.1. Introduction
  • 7.2. Private Cloud
  • 7.3. Public Cloud

8. Clinical Risk Grouping Solution Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Hospitals
  • 8.4. Long-Term Care Centers
  • 8.5. Payers

9. Americas Clinical Risk Grouping Solution Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Risk Grouping Solution Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Risk Grouping Solution Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Conduent, Inc.
  • 3. Dynamic Healthcare Systems, Inc. by Reveleer
  • 4. Evolent Health
  • 5. HBI Solutions, Inc.
  • 6. Health Catalyst Inc.
  • 7. Johns Hopkins University
  • 8. Lightbeam Health Solutions, LLC
  • 9. Optum Inc. by UnitedHealth Group
  • 10. Perahealth, Inc.

LIST OF FIGURES

  • FIGURE 1. CLINICAL RISK GROUPING SOLUTION MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CLINICAL RISK GROUPING SOLUTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CLINICAL RISK GROUPING SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL RISK GROUPING SOLUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL RISK GROUPING SOLUTION MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DASHBOARD ANALYTICS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RISK REPORTING SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SCORECARDS & VISUALIZATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. CLINICAL RISK GROUPING SOLUTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. CLINICAL RISK GROUPING SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023